article thumbnail

Pfizer, busy with $4B savings drive, plots even more cuts out to 2027

Fierce Pharma

Pfizer has made frequent headlines in recent months as it moves forward with a campaign to save $4 billion in annual costs by the end of this year. Pfizer has made frequent headlines in recent months as it moves forward with a campaign to save $4 billion in annual costs by the end of this year.

315
315
article thumbnail

Rapid microbiology testing market growth expected 2022 to 2027

European Pharmaceutical Review

percent between 2022 and 2027. Microbiology article: Pharmaceutical microbiology: key developments 2022… The post Rapid microbiology testing market growth expected 2022 to 2027 appeared first on European Pharmaceutical Review. According to the data, the market is forecasted to increase by $2,487.91 Don Whitley Scientific Ltd.,

Marketing 115
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

BioMarin outlines strategic roadmap to $4B revenue by 2027 amid portfolio, organizational shakeups

Fierce Pharma

In his nine months as CEO, BioMarin’s new chief Alexander Hardy has so far overseen shakeups in the company’s leadership team, a slimdown of its R&D program and decisive action on the future of | The company's game plan includes five new indications for dwarfism drug Voxzogo through 2031, which could represent a $5 billion opportunity covering (..)

Patients 130
article thumbnail

Oligonucleotide synthesis market to reach $16.7 billion by 2027

European Pharmaceutical Review

billion by 2027 during the forecast period, due to the rise in ongoing clinical trials for oligonucleotide-based therapies in key therapeutic sectors such as oncology. billion by 2027 appeared first on European Pharmaceutical Review. The research projected a compound annual growth rate (CAGR) of 16.8 percent from $7.7 billion in 2022.

article thumbnail

Pharmaceutical sterility testing market to grow from $2.07b in 2027

European Pharmaceutical Review

billion in 2027 at a compound annual growth rate (CAGR) of 12.5 The post Pharmaceutical sterility testing market to grow from $2.07b in 2027 appeared first on European Pharmaceutical Review. A recent market report showed that the global pharmaceutical sterility testing market is expected to grow from $2.07 billion in 2022 to $1.29

article thumbnail

Alkermes fends off generic versions of Vivitrol until 2027

Pharmaceutical Technology

Alkermes settled the lawsuit with Teva, allowing the latter to market the generic version of Vivitrol from January 2027.

article thumbnail

Novo Nordisk plans new $220M raw ingredients plant in Denmark

Fierce Pharma

Novo Nordisk Pharmatech expects the plant to be complete by 2027. billion Danish kroner ($220 million) to build a plant in Køge, Denmark, that will make raw materials, the company said Friday. The project will result in the creation of 50 new jobs, according to the company.